Navigation Links
Landauer, Inc. Sets Date and Time for Announcement of Fiscal Third Quarter 2008 Results
Date:7/17/2008

GLENWOOD, Ill., July 17 /PRNewswire-FirstCall/ -- Landauer, Inc. (NYSE: LDR), will release financial results for the fiscal third quarter of 2008 pre-market on Tuesday, July 29, 2008.

The company will host a conference call for investors on Tuesday, July 29, 2008, at 2:00 p.m. Eastern Time. Investors may access the live call by dialing 800-366-7640 (within the United States and Canada), or 303-262-2137 (international callers), or by visiting the "Investors" page on the company's website at http://www.landauerinc.com. Please log on to the website at least 15 minutes early to register, download and install any necessary audio software.

Investors may access a replay of the call by dialing 800-405-2236 (within the United States and Canada), or 303-590-3000 (international callers), passcode 11117488#, which will be available through Friday, August 29, 2008. The replay will also be available on Landauer's website for 90 days following the call.

About Landauer

Landauer is the leading provider of analytical services to determine occupational and environmental radiation exposure. For more than 50 years, the Company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, and other industries in which radiation poses a potential threat to employees. Landauer's services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from clients, and the analysis and reporting of exposure findings.

For the latest news releases and other corporate documents on Landauer Inc., visit http://www.landauerinc.com


'/>"/>
SOURCE Landauer, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Genmab A/S - Company Announcement
2. Advanced Life Sciences to Host Conference Call to Discuss Announcement Made Yesterday by FDA to Conduct Advisory Panel on CAP Drug Development
3. Announcement in Relation to the Movement in the ClinPhone Share Price
4. First Quarter 2008 Financial Results Announcement and Teleconference
5. The Lustgarten Foundation for Pancreatic Cancer Research Launches New Public Service Announcement Featuring Last Lecturer Dr. Randy Pausch
6. Neuftec Responds to a Fundamental Inaccuracy in Oxonica PLCs Regulatory Announcement
7. Exiqon: Major Shareholder Announcement
8. Cepheid Schedules Fiscal 2008 Second Quarter Financial Results Announcement and Webcast
9. CNS Response Announces Fiscal Third Quarter 2007 Results
10. Avitar Reports Third Quarter Financial Results for Fiscal 2007
11. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... CLEVELAND , June 27, 2016  Global ... average 4.6 percent through 2020 to $7.2 billion.  ... (food and beverages, cleaning products, biofuel production, animal ... and biotechnology, diagnostics, and biocatalysts). Food and beverages ... gains driven by increasing consumption of products containing ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly ... technologies, services and solutions to the healthcare market. The company's primary focus is ... manufacturing, sales and marketing strategies that are necessary to help companies efficiently bring ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology:
(Date:6/2/2016)... The Department of Transport Management (DOTM) ... million US Dollar project, for the , Supply ... Enrolment, and IT Infrastructure , to ... implementation of Identity Management Solutions. Numerous renowned international vendors participated ... was selected for the most compliant and innovative ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
Breaking Biology News(10 mins):